Reply to: Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'
Reply to: Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'
479-481
Almuhtaseb, H.
27fcdbb3-4784-483d-823c-c6dae6151578
Lotery, A.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
1 February 2018
Almuhtaseb, H.
27fcdbb3-4784-483d-823c-c6dae6151578
Lotery, A.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Almuhtaseb, H. and Lotery, A.
(2018)
Reply to: Comment on: 'One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration'.
Eye (Basingstoke), 32 (2), .
(doi:10.1038/eye.2017.212).
This record has no associated files available for download.
More information
e-pub ahead of print date: 20 October 2017
Published date: 1 February 2018
Identifiers
Local EPrints ID: 418236
URI: http://eprints.soton.ac.uk/id/eprint/418236
ISSN: 0950-222X
PURE UUID: 6213ac00-68b8-42a4-bfde-5bd15aff8cdf
Catalogue record
Date deposited: 26 Feb 2018 17:30
Last modified: 06 Jun 2024 01:41
Export record
Altmetrics
Contributors
Author:
H. Almuhtaseb
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics